G34

Retapamulin


Toggle HydrogenToggle Labels

Chemical Component Summary

NameRetapamulin
Identifiers[(1~{S},2~{R},3~{S},4~{S},6~{R},7~{R},8~{R},14~{R})-4-ethenyl-2,4,7,14-tetramethyl-3-oxidanyl-9-oxidanylidene-6-tricyclo[5.4.3.0^{1,8}]tetradecanyl] 2-[[(1~{S},5~{R})-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl]ethanoate
FormulaC30 H47 N O4 S
Molecular Weight517.763
TypeNON-POLYMER
Isomeric SMILESC[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C
InChIInChI=1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22-,24-,26+,27+,28-,29+,30+/m1/s1
InChIKeySTZYTFJPGGDRJD-NHUWBDDWSA-N

Chemical Details

Formal Charge0
Atom Count83
Chiral Atom Count11
Bond Count87
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB01256 
NameRetapamulin
Groups approved
DescriptionRetapamulin, marketed by GlaxoSmithKline as the ointment Altabax, is an antibiotic for skin infections like impetigo. It was approved by the FDA in April 2007.
Synonyms
  • Retapamulin
  • Retapamulina
Brand Names
  • Altabax
  • Altargo
IndicationFor use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm<sup>2</sup> in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.
Categories
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antibiotics for Topical Use
  • Cytochrome P-450 CYP3A Substrates
  • Cytochrome P-450 CYP3A4 Substrates
ATC-CodeD06AX13
CAS number224452-66-8

Drug Targets

NameTarget SequencePharmacological ActionActions
50S ribosomal protein L3MTKGILGKKVGMTQIFTESGEFIPVTVIEATPNVVLQVKTVETDGYEAVQ...unknowninhibitor
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682